These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2257058)

  • 1. Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate.
    Frölich L; Strauss M; Kornhuber J; Hoyer S; Sorbi S; Riederer P; Amaducci L
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):169-78. PubMed ID: 2257058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
    Hruska RE; Ludmer LM; Pert A; Bunney WE
    J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat brain pyruvate dehydrogenase by thiamine analogs.
    Kandiko CT; Smith D; Yamamoto BK
    Biochem Pharmacol; 1988 Nov; 37(22):4375-80. PubMed ID: 3196360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Holeboard maze-learning deficits and brain monoaminergic neurotransmitter concentrations in rats after intracerebroventricular injection of 3-bromopyruvate.
    Froelich L; Ding A; Hoyer S
    Pharmacol Biochem Behav; 1995 Aug; 51(4):917-22. PubMed ID: 7675877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pyruvate dehydrogenase complex activity by 3-bromopyruvate affects blood platelets responses in type 2 diabetes.
    Michno A; Grużewska K; Bielarczyk H; Zyśk M; Szutowicz A
    Pharmacol Rep; 2020 Feb; 72(1):225-237. PubMed ID: 32016856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate dehydrogenase activity in the rat cerebral cortex following cerebral ischemia.
    Cardell M; Koide T; Wieloch T
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):350-7. PubMed ID: 2715207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
    Lerer B; Stanley M; Demetriou S; Gershon S
    J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of chronic ethanol on muscarinic receptor binding in rat brain.
    Rothberg BS; Hunter BE; Walker DW; Anderson JF; Anderson KJ
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1613-7. PubMed ID: 8986212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
    Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and distribution of muscarinic cholinergic receptors in rat striatal micropunched tissue homogenates.
    Takano Y; Uchimura K; Kohjimoto Y; Kamiya H
    Eur J Pharmacol; 1981 Apr; 70(4):559-64. PubMed ID: 7238577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats.
    Ma T; Kramer RE; Baker RC; Fan LW; Ho IK
    J Neurosci Res; 2003 Jan; 71(1):138-45. PubMed ID: 12478623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between activation state of pyruvate dehydrogenase complex and rate of pyruvate oxidation in isolated cerebro-cortical mitochondria: effects of potassium ions and adenine nucleotides.
    Lai JC; Sheu KF
    J Neurochem; 1985 Dec; 45(6):1861-8. PubMed ID: 3840524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.